Alkeon Capital Management LLC Keros Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

$58.2 Billion
Q3 2024

A detailed history of Alkeon Capital Management LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 1,897,601 shares of KROS stock, worth $103 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,897,601

Previous 1,598,907 18.68%

Holding current value

$103 Million

Previous $73.1 Million 50.8%

% of portfolio

0.19%

Previous 0.12%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$41.68 - $58.07 $12.4 Million - $17.3 Million	298,694 Added 18.68%	1,897,601 $110 Million
Q1 2024 May 14, 2024	BUY	$41.26 - $70.48 $4.13 Million - $7.05 Million	100,000 Added 6.67%	1,598,907 $106 Million
Q4 2023 Feb 13, 2024	SELL	$27.12 - $41.05 $4.82 Million - $7.29 Million	-177,615 Reduced 10.59%	1,498,907 $59.6 Million
Q2 2023 Aug 11, 2023	SELL	$37.26 - $51.01 $55,740 - $76,310	-1,496 Reduced 0.09%	1,676,522 $67.4 Million
Q1 2023 May 12, 2023	BUY	$41.44 - $59.32 $11.8 Million - $16.9 Million	285,616 Added 20.51%	1,678,018 $71.7 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $7.24 Million - $9.5 Million	183,580 Added 15.19%	1,392,402 $66.9 Million
Q3 2022 Nov 10, 2022	BUY	$27.8 - $40.12 $900,414 - $1.3 Million	32,389 Added 2.75%	1,208,822 $45.5 Million
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $7.03 Million - $18.1 Million	270,000 Added 29.79%	1,176,433 $32.5 Million
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $842,400 - $1.19 Million	-20,000 Reduced 2.16%	906,433 $49.3 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $8.31 Million - $14.2 Million	225,000 Added 32.08%	926,433 $54.2 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $58,715 - $87,682	-2,006 Reduced 0.29%	701,433 $27.7 Million
Q2 2021 Aug 16, 2021	BUY	$42.4 - $70.11 $7.63 Million - $12.6 Million	180,000 Added 34.39%	703,439 $29.9 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $71,172 - $99,219	1,318 Added 0.25%	523,439 $32.2 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $17.7 Million - $40.7 Million	492,121 Added 1640.4%	522,121 $36.8 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $602,400 - $1.21 Million	30,000 New	30,000 $1.13 Million

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.39B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account

Alkeon Capital Management LLC Keros Therapeutics, Inc. Transaction History